Aimed Alliance’s Op-Ed on REMS Featured in The Hill: “Drug Safety Really Matters”
The Hill has published an op-ed by Aimed Alliance’s Director of Public Policy, Stacey L.…
Browsing: Advocacy
Aimed Alliance Attends Patients Rising’s National Public Health Week Meeting
Patients Rising recently marked National Public Health Week with a meeting and webcast in Sacramento,…
Aimed Alliance Signs on to MAPRx Coalition Letter Calling on MedPAC To Improve Medicare Appeals Process
Aimed Alliance Signs on to Letter Opposing New Medicare Part B Payment Model that May Impede Access
Aimed Alliance is one of over 50 organizations that signed on to a letter urging…
Aimed Op-Ed Featured in The Hill: “Congress: Keep the Nation’s Drug Safety System Intact”
The Hill has published an op-ed by Aimed Alliance’s Director of Public Policy, Stacey L.…
Aimed Alliance Signs on to Testimony in Opposition to Kan. Bill that Would Reinstate Burdensome Step Therapy Protocols
New Aimed Alliance Article, Published in Journal of Pharmaceutical Policy and Practice, Calls for Preservation of REMS Program
Aimed Alliances Urges Congress to Keep the Current Risk Evaluation and Mitigation Strategies (REMS) Program Intact…
Aimed Alliance Testifies at FDA Committee Hearing on Novel New Drug
Aimed Alliance’s Director of Medical Affairs, Dr. Shannon Ginnan, testified on an innovative buprenorphine subdermal…